NYU Physician Magazine now a free iPad app

NYU Langone Medical Center, one of the nation's premier academic medical centers, announced today the magazine of NYU School of Medicine, NYU Physician, is now available as a free iPad app in the iTunes App Store.

NYU Physician, published three times a year, provides news and insights about important advances in biomedical research and innovations in health care. Each issue features a trio of in-depth articles focused on specific topics, from how aging "baby boomers" are changing the face of orthopaedic care to how the genome is shaping the diagnosis and treatment of diseases including cancer and to the key role the five senses play in our daily lives. The magazine also includes individual stories highlighting the experiences of real patients, doctors and scientists, while a recurring "News from Medicine" section highlights four to five key research initiatives underway at the medical center that are laying the groundwork for new and novel therapies.

"We are thrilled to now be able to share the discoveries of our scientists and our cutting-edge clinical care with anyone who has an ," said Deborah Loeb Bohren, vice president, office of communications and public affairs. "We believe that consumers, physicians and scientists alike will enjoy reading NYU Physician and learning about the latest issues in health care and ."

The NYU iPad app is accessible in the Medical Category of the Apple App Store. The magazine has garnered multiple awards for excellence in writing and design from organizations including the Association of Creative and Marketing Professionals, the Healthcare and Marketing Association, PR News and MarComm. The magazine is also available via the NYU Langone website at http://communications.med.nyu.edu/.

add to favorites email to friend print save as pdf

Related Stories

Clinical trial evaluating brain cancer vaccine is underway

Oct 19, 2007

A clinical trial evaluating a brain cancer vaccine in patients with newly diagnosed brain cancer has begun at NYU Medical Center. The study will evaluate the addition of the vaccine following standard therapy with surgery ...

Recommended for you

Amgen misses 1Q views as higher costs cut profit

Apr 22, 2014

Despite higher sales, biotech drugmaker Amgen's first-quarter profit fell 25 percent as production and research costs rose sharply, while the year-ago quarter enjoyed a tax benefit. The company badly missed ...

Valeant, Ackman make $45.6B Allergan bid

Apr 22, 2014

Valeant Pharmaceuticals and activist investor Bill Ackman have unveiled details of their offer to buy Botox maker Allergan, proposing a cash-and-stock deal that could be worth about $45.6 billion.

User comments